Impella Heart Pump Controller Injury & Death Lawsuit Lawyers

FDA Confirms Class I Recall of Impella Heart Pump Controllers Following Reports of Deaths and Serious Injuries

What Parker Waichman LLP Found

• Highest recall classification: The FDA designated the affected Impella controller recall as Class I, its most serious category.
• Reported fatalities and injuries: The safety issue has been associated with three deaths and 37 serious injuries.
• Identified equipment defect: A purge flag component failure can prevent proper recognition of the purge disc.
• Potential legal claims: Patients may have product liability claims when a controller defect causes additional injury.
• Critical evidence: Hospital records, device logs, alarm histories, and equipment identification can help establish liability.

The U.S. Food and Drug Administration (FDA) has confirmed a Class I recall involving Automated Impella Controllers (AICs) manufactured by Johnson & Johnson MedTech. The recall follows reports of 37 serious injuries and three deaths associated with problems involving the devices’ ability to recognize an essential component of the heart pump’s purge system. For patients who depend on mechanical circulatory support during critical cardiac procedures, equipment malfunctions can create dangerous complications when there is little room for error.

Impella heart pumps are used in hospitals to temporarily assist patients whose hearts cannot circulate enough blood to meet their bodies’ needs. These devices may be used during certain high-risk cardiac procedures or when patients experience severe heart failure or cardiogenic shock. The Automated Impella Controller operates and monitors the pump, providing important information and alarms to the medical professionals responsible for maintaining circulatory support.

According to the September 25, 2026, report from Cardiovascular Business, the FDA finalized the Class I recall after identifying problems involving the controller’s purge flag component. A Class I classification represents the FDA’s most serious recall category because continued use of an affected product could cause serious adverse health consequences or death.

Patients who suffered unexpected complications while receiving Impella support may have grounds to investigate whether defective medical equipment contributed to their injuries. Families who lost loved ones during procedures involving these devices may also have potential wrongful death claims, depending on the medical evidence and applicable state law.

Which Impella Heart Pump Controllers Are Included in the FDA Recall?

The recall involves three packaged Automated Impella Controller products used with Impella mechanical circulatory support systems.

The recalled products are associated with Johnson & Johnson MedTech, which acquired Impella manufacturer Abiomed in 2022.

Importantly, the recall does not necessarily mean that every patient supported by an Impella device was exposed to a defective controller or that every complication involving an Impella pump resulted from this particular malfunction. Determining whether a specific device was affected requires examining hospital equipment records, controller identification information, procedure documentation, and the circumstances surrounding the patient’s treatment.

Although the FDA identified the devices for removal from use and distribution, the manufacturer’s instructions permitted hospitals to continue using existing inventory while awaiting replacements, subject to appropriate precautions. Patients should not interpret the recall as an instruction to discontinue necessary cardiac treatment. Decisions involving active circulatory support must be made by the treating medical team.

What Defect Caused the Impella Controller Recall?

The reported malfunction involves the purge flag component within the controller’s purge pressure sensor assembly. This component helps the Automated Impella Controller recognize the purge cassette connection.

The Impella purge system is important because it delivers purge fluid through the device to help maintain proper pump operation. The controller monitors this system and alerts medical professionals when it detects certain abnormalities.

When the purge flag component fails, the controller may incorrectly indicate that the purge disc is disconnected or cannot be detected. The specific warning depends on whether the malfunction occurs during initial setup or while the patient is already receiving mechanical circulatory support.

During setup, the controller may display a “Purge Disc Disconnected” alarm. During active support, it may display a “Purge Disc Not Detected” alarm. The manufacturer’s recommended response includes reinserting the purge disc and switching to a backup controller if the problem cannot be corrected.

According to the reported safety instructions, the Impella pump should continue functioning during an active-support purge flag failure while clinicians prepare to exchange the controller. Nevertheless, any unexpected equipment malfunction involving a critically ill cardiac patient warrants immediate attention.

A product liability investigation may examine whether the component was adequately designed, whether manufacturing defects contributed to the failure, whether the malfunction was foreseeable, and whether the manufacturer provided sufficient instructions and warnings to healthcare providers.

How Could a Defective Impella Controller Harm a Patient?

Patients requiring Impella support frequently have serious underlying cardiovascular conditions. Some are undergoing complex cardiac interventions, while others need temporary mechanical support because their hearts cannot adequately maintain blood circulation.

A controller malfunction can create additional clinical challenges during an already dangerous medical situation. Even when the pump continues operating, medical professionals may need to troubleshoot alarms, evaluate the purge system, obtain backup equipment, and replace the controller without compromising the patient’s care.

Potential complications that may require investigation include interruptions in circulatory support, worsening cardiac instability, inadequate organ perfusion, and injuries associated with emergency interventions. Depending on the circumstances, these events could contribute to kidney injury, neurological complications, prolonged hospitalization, or death.

These outcomes are not established consequences of every purge flag failure. The FDA’s reported injury and death figures do not, by themselves, establish that each outcome was caused by a defective controller.

A thorough investigation must distinguish between complications caused by a patient’s underlying cardiac disease and additional harm attributable to a malfunctioning medical device. This distinction is especially important when evaluating claims involving critically ill patients who already faced substantial medical risks.

Multiple Impella Recalls Raise Questions About Device Safety

The September 2026 Class I recall follows several earlier safety actions involving Impella controllers and related equipment.

During 2025 and 2026, federal regulators reported concerns involving controller hardware, durability, cybersecurity, and other operational issues. Separate recalls also addressed problems involving purge cassettes, introducer kits, and introducer sheaths used with certain Impella systems.

These recalls do not necessarily involve the same defect or establish that all Impella products are unsafe. However, the repeated safety actions make it important to identify precisely which equipment was used during a patient’s treatment.

In a potential lawsuit, earlier complaints, service records, engineering evaluations, and recall communications may help establish when a manufacturer became aware of a particular hazard. Attorneys may also examine whether corrective measures were implemented promptly and whether hospitals received adequate information about equipment risks.

Johnson & Johnson MedTech has stated that the purge cassette recognition issue occurred in approximately 0.2% of cases and that existing monitoring and alarms help support continued device use. The company has also emphasized the importance of maintaining continuity of patient care.

Impella Heart Pump Controller Recall Lawsuit FAQs

Can I File a Lawsuit If I Was Injured While Using an Impella Heart Pump?

You may have grounds for a lawsuit if an Impella controller malfunction caused or contributed to a serious injury. An attorney would need to review your medical records, identify the equipment used, and determine whether the reported defect played a role in your complications. Not every injury occurring during Impella treatment results from defective equipment, so medical causation is essential.

Can Families File a Wrongful Death Lawsuit After an Impella Controller Malfunction?

Potentially, yes. When a patient dies following a suspected medical device malfunction, qualifying family members or estate representatives may be able to pursue a wrongful death or survival action. The investigation must establish a legally sufficient connection between the alleged defect and the death. Eligibility, recoverable damages, and filing deadlines depend on the state whose law governs the claim.

What If the Hospital Never Told Me That an Impella Controller Was Recalled?

A patient may still have a potential claim even without receiving a recall notification. Hospital records, device identification numbers, maintenance records, and procedure documentation can help determine whether recalled equipment was used. An attorney can investigate whether the equipment malfunctioned and whether that malfunction caused additional injury. Lack of notification alone does not establish a viable product liability lawsuit.

Do I Need to Prove That the Impella Controller Was Defective?

Generally, a product liability claim requires evidence establishing an actionable defect or other legal basis for liability, along with causation and damages. The specific elements depend on applicable law. Technical records, FDA recall information, medical documentation, and testimony from qualified professionals may help support a claim. A recall is important evidence but does not automatically prove liability in an individual case.

How Long Do I Have to File an Impella Heart Pump Lawsuit?

Filing deadlines vary by jurisdiction and the nature of the claim. Some states apply discovery rules that may affect when the filing period begins, while other laws impose additional restrictions. Wrongful death claims may follow different deadlines from personal injury claims. Because missing an applicable deadline can prevent recovery, patients and families should obtain a timely review of their circumstances.

Contact Parker Waichman LLP for a Free Impella Heart Pump Recall Lawsuit Consultation

If you or a loved one suffered serious complications while receiving treatment involving an Impella heart pump, defective medical equipment may have contributed to the injuries. Patients and families deserve answers about whether the equipment functioned properly, whether healthcare providers received adequate safety warnings, and whether a preventable malfunction caused additional harm.

Parker Waichman LLP is a national personal injury law firm representing individuals and families pursuing claims involving allegedly defective medical devices and other dangerous products. The firm can investigate the circumstances surrounding an Impella-related injury, review available medical and equipment records, and evaluate potential claims against legally responsible parties.

Call 1-800-YOUR-LAWYER (1-800-968-7529) today for a free consultation about your potential Impella heart pump controller recall lawsuit. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.